AtriCure, Inc. ATRC
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $534.5M | +15% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $400.8M | +15% | FY ending Dec 31, 2025 |
| Operating income | $-9.4M | +76% | FY ending Dec 31, 2025 |
| Net income | $-11.4M | +74% | FY ending Dec 31, 2025 |
| Earnings per share | $-0.24 | +75% | FY ending Dec 31, 2025 |
| Research & development | $99.2M | +3% | FY ending Dec 31, 2025 |
| Cash from operations | $57.3M | +370% | FY ending Dec 31, 2025 |
| Capital spending | $9.1M | -21% | FY ending Dec 31, 2025 |
| Cash | $167.4M | +36% | FY ending Dec 31, 2025 |
| Long-term debt | $61.9M | +0% | FY ending Dec 31, 2025 |
| Shareholders' equity | $491.9M | +7% | FY ending Dec 31, 2025 |
| Shares outstanding | 50M | +2% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 17 sales ($4.4M) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Salvatore PriviteraChief Technical Officer | Soldpre-set plan | 4,519 | $60.00 | $271K | Sep 23, 2026 |
| Regina E GrovesDirector | Sold | 5,313 | $54.22 | $288K | Sep 11, 2026 |
| Salvatore PriviteraChief Technical Officer | Soldpre-set plan | 3,657 | $55.00 | $201K | Sep 8, 2026 |
| Salvatore PriviteraChief Technical Officer | Soldpre-set plan | 7,763 | $52.50 | $408K | Sep 2, 2026 |
| Karl S. DahlquistChief Legal Officer | Sold | 9,370 | $48.89 | $458K | Aug 24, 2026 |
| Karen PrangeDirector | Sold | 3,564 | $38.80 | $138K | Aug 5, 2026 |
| Maggie YuenDirector | Sold | 3,500 | $38.42 | $134K | Aug 5, 2026 |
| Justin J NozneskyChief Mktg & Strategy Officer | Sold | 6,182 | $38.80 | $240K | Jul 29, 2026 |
| Sven WehrweinDirector | Sold | 25,000 | $37.84 | $946K | Jul 28, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Sold | 6,000 | $38.88 | $233K | Jul 28, 2026 |
| Karen PrangeDirector | Sold | 3,000 | $28.65 | $86K | May 20, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Sold | 5,000 | $28.13 | $141K | May 15, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Sold | 5,000 | $29.83 | $149K | Mar 12, 2026 |
| Justin J NozneskyChief Mktg & Strategy Officer | Sold | 5,166 | $37.29 | $193K | Nov 26, 2025 |
| Sven WehrweinDirector | Sold | 4,967 | $38.00 | $189K | Nov 25, 2025 |
| Sven WehrweinDirector | Sold | 5,033 | $37.32 | $188K | Nov 24, 2025 |
| Maggie YuenDirector | Sold | 3,000 | $35.72 | $107K | Nov 21, 2025 |
Other insider moves (36): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Michael H CarrelPresident, CEO, & Director, Director | Gift2 fills | 4,700 | – | – | Jul 30, 2026 |
| Sven WehrweinDirector | Option exercise | 25,000 | $19.95 | $499K | Jul 28, 2026 |
| Michael H CarrelPresident, CEO, & Director, Director | Award | 636 | $23.78 | $15K | Jun 30, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Award | 636 | $23.78 | $15K | Jun 30, 2026 |
| Karl S. DahlquistChief Legal Officer | Award | 636 | $23.78 | $15K | Jun 30, 2026 |
| Salvatore PriviteraChief Technical Officer | Award | 636 | $23.78 | $15K | Jun 30, 2026 |
| Douglas J SeithChief Operating Officer | Award | 527 | $23.78 | $13K | Jun 30, 2026 |
| Karen PrangeDirector | Award | 6,144 | – | – | May 18, 2026 |
| Deborah H TelmanDirector | Award | 6,144 | – | – | May 18, 2026 |
| Maggie YuenDirector | Award | 6,144 | – | – | May 18, 2026 |
| Shlomo NachmanDirector | Award | 6,144 | – | – | May 18, 2026 |
| B Kristine JohnsonDirector | Award | 6,144 | – | – | May 18, 2026 |
| Regina E GrovesDirector | Award | 6,144 | – | – | May 18, 2026 |
| Sven WehrweinDirector | Award | 6,144 | – | – | May 18, 2026 |
| Robert S. WhiteDirector | Award | 6,144 | – | – | May 18, 2026 |
| Robert S. WhiteDirector | Option exercise | 10,000 | $14.99 | $150K | Mar 10, 2026 |
| Michael H CarrelPresident, CEO, & Director, Director | Gift2 fills | 6,000 | – | – | Mar 6, 2026 |
| Michael H CarrelPresident, CEO, & Director, Director | Tax withholding | 72,777 | $31.26 | $2.3M | Mar 1, 2026 |
| Angela L WirickChief Financial Officer | Tax withholding | 22,965 | $31.26 | $718K | Mar 1, 2026 |
| Douglas J SeithChief Operating Officer | Tax withholding | 22,948 | $31.26 | $717K | Mar 1, 2026 |
| Karl S. DahlquistChief Legal Officer | Tax withholding | 15,687 | $31.26 | $490K | Mar 1, 2026 |
| Justin J NozneskyChief Mktg & Strategy Officer | Tax withholding | 15,586 | $31.26 | $487K | Mar 1, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Tax withholding | 15,585 | $31.26 | $487K | Mar 1, 2026 |
| Salvatore PriviteraChief Technical Officer | Tax withholding | 13,127 | $31.26 | $410K | Mar 1, 2026 |
| Michael H CarrelPresident, CEO, & Director, Director | Award2 fills | 169,898 | – | – | Mar 1, 2026 |
| Justin J NozneskyChief Mktg & Strategy Officer | Award2 fills | 43,189 | – | – | Mar 1, 2026 |
| Salvatore PriviteraChief Technical Officer | Award2 fills | 45,588 | – | – | Mar 1, 2026 |
| Vinayak DoraiswamyChief Scientific Officer | Award2 fills | 45,588 | – | – | Mar 1, 2026 |
| Angela L WirickChief Financial Officer | Award2 fills | 63,088 | – | – | Mar 1, 2026 |
| Douglas J SeithChief Operating Officer | Award2 fills | 67,918 | – | – | Mar 1, 2026 |
| Karl S. DahlquistChief Legal Officer | Award2 fills | 43,189 | – | – | Mar 1, 2026 |
| Douglas J SeithChief Operating Officer | Award | 257 | $27.37 | $7,034 | Dec 31, 2025 |
| Michael H CarrelPresident, CEO, & Director, Director | Gift | 4,000 | – | – | Dec 10, 2025 |
| Sven WehrweinDirector | Option exercise | 4,967 | $19.95 | $99K | Nov 25, 2025 |
| Sven WehrweinDirector | Option exercise | 5,033 | $19.95 | $100K | Nov 24, 2025 |
| Michael H CarrelPresident, CEO, & Director, Director | Gift | 6,000 | – | – | Nov 13, 2025 |
Trades by members of Congress
1 member reported 3 buys and 1 sale since May 6, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. D | Sold some | $1,001–$15K | Sep 29, 2026 | Oct 12, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Aug 20, 2026 | Sep 10, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | Mar 3, 2026 | Apr 7, 2026 | Self |
| Gilbert Ray Cisneros, Jr. D | Bought | $1,001–$15K | May 6, 2025 | Jun 6, 2025 | Self |
Latest SEC filings
- Insider plans to sell 144 · Sep 23, 2026
- Insider plans to sell 144 · Sep 11, 2026
- Insider plans to sell 144 · Sep 8, 2026
- Insider plans to sell 144 · Sep 2, 2026
- Insider plans to sell 144 · Aug 24, 2026
- Insider plans to sell 144 · Aug 5, 2026
- Insider plans to sell 144 · Aug 5, 2026
- Insider plans to sell 144 · Jul 29, 2026
- Insider plans to sell 144 · Jul 28, 2026
- Insider plans to sell 144 · Jul 28, 2026
- Quarterly report 10-Q · Jul 27, 2026
- News filing: Quarterly results 8-K · Jul 23, 2026
- Insider plans to sell 144 · May 20, 2026
- News filing: Executive or board change, Shareholder vote results 8-K · May 19, 2026
- Insider plans to sell 144 · May 15, 2026
- Quarterly report 10-Q · May 6, 2026
- News filing: Quarterly results 8-K · May 5, 2026
- Shareholder meeting proxy DEF 14A · Apr 6, 2026
- Insider plans to sell 144 · Mar 12, 2026
- Annual report 10-K · Feb 19, 2026
- News filing: Quarterly results 8-K · Feb 17, 2026
- News filing: Signed a major agreement, Quarterly results, Took on new debt 8-K · Jan 12, 2026
- Insider plans to sell 144 · Nov 26, 2025
- Insider plans to sell 144 · Nov 25, 2025
- Insider plans to sell 144 · Nov 24, 2025
About AtriCure, Inc.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Mason, OH
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- Nasdaq
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 1323885
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.